Sorted By:

Relevance


A New World of Medicine: New GOBOLDLY ads showcase groundbreaking scientific advancements

PhRMA  |  Blog Post

Both New World and Together illustrate the incredible innovation happening in medical science and how industry scientists are changing the way we treat the most complex and debilitating diseases.
http://catalyst.phrma.org/new-world-of-medicine

PhRMA Announces Promotions of Key Federal Affairs Staff

PhRMA  |  Press Release

PhRMA members alone invested an estimated $45.8 billion in 2009 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-announces-promotions-of-key-federal-affairs-staff

Print Ad: Let's Talk About Cost

PhRMA  |  Graphic

Learn more at phrma.org/letstalkcost. 
http://www.phrma.org/graphic/print-ad-let-s-talk-about-cost

New prostate cancer treatment will get its first test in Omaha

From Hope To Cures  |  From Our Network

The society estimates that 220,800 new cases were found in 2015 and that 27,540 men died of the disease.
http://www.fromhopetocures.org/new-prostate-cancer-treatment-will-get-its-first-test-in-omaha

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

PhRMA  |  Press Release

Scangos was appointed CEO of Biogen Idec in June 2010.
http://www.phrma.org/press-release/pfizer-s-ian-read-becomes-phrma-board-chairman-ken-frazier-george-scangos-assume-new-posts

Rare Disease Day Should Last All Year

PhRMA  |  Blog Post

For example, America's biopharmaceutical research companies are today working on more than 400 new medicines to help treat a wide variety of rare diseases.
http://catalyst.phrma.org/rare-disease-day-should-last-all-year

Collaboration Is Key in Researching and Developing New Medicines

Chartpack  |  From Our Network

The Accelerating Medicines Partnership, Biomarkers Consortium and Lung Cancer Master Protocol are a few examples of current collaborative efforts.
http://chartpack.phrma.org/biophrma-chartpack/research-and-development/collaboration-is-key-in-researching-and-developing-new-medicines

PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization

PhRMA  |  Press Release

PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-statement-regarding-prescription-drug-user-fee-act-reauthorization2

Report Shows Buffalo Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases

PhRMA  |  Press Release

PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines.
http://www.phrma.org/press-release/report-shows-buffalo-companies-playing-key-role-in-development-of-new-medicines-for-wide-range-of-diseases

New Chart Pack: Biopharmaceuticals in Government Programs

PhRMA  |  Blog Post

  Medicines in Medicare Part D Beneficiaries Save Through Plan Competition and Manufacturer Negotiations   Medicines in Medicare Part B Program Spending on Prescription Medicines Accounted for About 8% of Part B Spending in 2012   Medicines in Medicaid On Average, About 60% of the Initial Cost of Brand Medicines is Returned to States Through Rebates   Medicines in Veterans Affairs VA Formulary Covers Fewer Drugs Than Part D Medicines in 340B Without Significant Reforms 340B Will Continue to Grow as Uninsured Rate Declines Check out PhRMA’s other chart pack resources here and check back with our Medicare Monday series and 340B Spotlight as we take a deeper look at some of these charts in the coming weeks.
http://catalyst.phrma.org/new-chart-pack-biopharmaceuticals-in-government-programs

Negotiators Must Say “Aloha” to a 21st Century Trade Deal

PhRMA  |  Blog Post

Since, on average, it takes 10-15 years and more than $2 billion to bring a new medication to market, innovators will only be willing to undertake that investment if they have incentives to do so.
http://catalyst.phrma.org/negotiators-must-say-aloha-to-a-21st-century-trade-deal

How to Get Payment Reforms Right

Access Better Coverage  |  From Our Network

Medicare currently follows this model, and it should remain a part of any new payments models.
http://www.accessbettercoverage.org/social-news/how-to-get-payment-reforms-right

In biopharmaceutical research, if at first you don’t succeed, try again

PhRMA  |  Blog Post

See one biopharmaceutical researcher’s .youtube.com/watch?
http://catalyst.phrma.org/in-biopharmaceutical-research-if-at-first-you-dont-succeed-try-again

New report highlights need to speed patent examination

PhRMA  |  Blog Post

The United Kingdom’s Intellectual Property Office estimated that combined losses from each year of backlog in the U.S.
http://catalyst.phrma.org/new-report-highlights-need-to-speed-patent-examination

New Policy Solutions for Innovative Treatment Delivery

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
http://www.phrma.org/press-release/phrma-releases-new-policy-solutions-for-delivering-innovative-treatments-to-patients

#GOBOLDLY - New World TV

PhRMA  |  Video

Welcome to a new world where immunotherapy unleashes your body’s own immune system to fight cancer.
http://www.phrma.org/video/goboldly-new-world-tv

Breast Cancer Costs Go Up, But So Does Survival

From Hope To Cures  |  From Our Network

However, few studies have looked at the association between trends in costs and survival outcomes.
http://www.fromhopetocures.org/breast-cancer-costs-go-up-but-so-does-survival

New Report: Clinical Trials and the Impact on State Economies

PhRMA  |  Blog Post

This analysis provides a new lens through which to view the economic and scientific footprint of the U.S. biopharmaceutical industry. 
http://catalyst.phrma.org/new-report-clinical-trials-and-the-impact-on-state-economies

PhRMA Statement Regarding User Fee Act Reauthorization

PhRMA  |  Press Release

This enhanced review model targets completion of FDA assessments of efficacy and safety within the first review cycle and is intended to reduce the overall time until new medicines become available to patients, while maintaining FDA’s gold standard of safety and efficacy.
http://www.phrma.org/press-release/phrma-statement-regarding-user-fee-act-reauthorization

New Survey: Patients’ share of health care costs continues to grow

PhRMA  |  Blog Post

Clear information about out-of-pocket costs can help patients make better health coverage decisions.
http://catalyst.phrma.org/new-survey-patients-share-of-health-care-costs-continue-to-grow

Clinical Trials Awareness Week: Celebrating the impact of clinical research

PhRMA  |  Blog Post

Perhaps no partner is more critical to the R&D process than patients, and our nation’s innovative biopharmaceutical companies are increasingly seeking to incorporate the patient perspective throughout all elements of the R&D process.
http://catalyst.phrma.org/clinical-trials-awareness-week-celebrating-the-impact-of-clinical-research

FDA Modernization

PhRMA  |  From PhRMA

Solutions
http://www.phrma.org/advocacy/research-development/fda-modernization

Collaboration Is Key in Researching and Developing New Medicines

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-2/collaboration-is-key-in-researching-and-developing-new-medicines

Health Care Communications

PhRMA  |  From PhRMA

Physician Survey on Pharmaceutical Company Activities and Information Read the results of a survey that emphasizes the value of biopharmaceutical company engagement with healthcare providers. 
http://www.phrma.org/media/health-care-communications

New York's 2016 Exchange Plans

PhRMA  |  Fact Sheet

States can continue to protect patients in their state through the following actions: Enforcing non-discrimination requirements, which apply to benefit design and provider networks; Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.phrma.org/fact-sheet/new-york-s-2016-exchange-plans

You have reviewed the first 150 results out of 2024. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next